References
- Dahlöf B, Devereux RB, Lindholm LH, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359(9311):995–1003.
- Borlaug BA, Redfield M. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123(18):2006–2014.
- Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009;13(32):1–232.
- Maisel AS, Nakao K, Ponikowski P, et al. Japanese-Western consensus meeting on biomarkers: Executive summary. Int Heart J. 2011;52(5):253–265.
- Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539–2550.
- Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiography. 2009;10(2):165–193.
- Shuai X-X, Chen Y-Y, Lu Y-X, et al. Diagnosis of heart failure with presrved ejection fraction: which parameters and diagnostic strategies are more valuable? Eur Heart J. 2011;13(7):737–745.